Invest and Sell Eikon Therapeutics Stock

Q: How to sell Eikon Therapeutics stock?

If you hold private company shares of Eikon Therapeutics - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Eikon Therapeutics stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Enterprise Value

Access Eikon Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Eikon Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Roger Perlmutter

President, Chief Executive Officer & Chairman

Alfred Bowie Ph.D

Chief Financial Officer

Russ Berman

Chief Technology Officer

Ashish Kheterpal

Chief Information Officer

Daniel Anderson Ph.D

Chief Scientific Officer

Benjamin Thorner JD

Chief Business Officer & General Counsel

Roy Baynes Ph.D

Chief Medical Officer & Executive Vice President

Board Members

James Tananbaum MD

Foresite Capital Management

Joshua Wolfe

Lux Capital

Eikon Therapeutics stock FAQs

Can you buy Eikon Therapeutics stock?

As Eikon Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Eikon Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Eikon Therapeutics stock?

To invest in a private company like Eikon Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Eikon Therapeutics stock?

Yes, you may be able to sell your Eikon Therapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Eikon Therapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Eikon Therapeutics stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Eikon Therapeutics a public company?

No, Eikon Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Eikon Therapeutics’ stock price?

Eikon Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Eikon Therapeutics’ private market stock price with Forge Data.

What is Eikon Therapeutics’ stock ticker symbol?

Eikon Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

FIERCE BIOTECH 06/01/2023

Eikon snaps up clinical pipeline thanks to 'buyer's market,' while internal pipeline remains covert

Eikon Therapeutics emerged with the promise of Nobel Prize-winning molecule tracking technology. But now, CEO Roger Perlmutter, M.D., Ph.D., and co. are using their more than $600 million war chest for something else: buying up clinical-stage drugs.

BIO SPACE 06/01/2023

Eikon Acquires Broad Development Pipeline, Raises $106M in Series C Funding

Led by biopharma titan Roger Perlmutter, Eikon Therapeutics kicked off 2022 with a Series B financing worth $517.8 million. The Bay Area-based biotech made another splash Thursday, announcing a $106 million Series C raise and the acquisition of exclusive, global rights to several early- to mid-stage assets.

New York Business Journal 07/31/2022

Biotech company Eikon Therapeutics to open New York City operations base

Eikon Therapeutics, a drug discovery and development company, has signed a lease to open a New York City operations base at the Alexandria Center for Life Science at 430 E. 29th St.

Fierce Biotech 06/30/2022

Fierce Next Gen: Eikon drops hints at early pipeline, plans for $660M-plus reservoir

After raising more than $660 million in less than a year, Eikon Therapeutics' future plans are coming into clearer view, with an oncology pipeline underway as the star-studded biotech looks to capitalize on—and expand—Nobel Prize-winning tech.

Eikon Therapeutics Stock

Register To Buy and Sell Shares